← Open Payments lookup

JANET DIAZ: Open Payments

NPI 1639764368 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$228 in 10 payments from 9 companies in 2025. Trend: 2023 $134 · 2024 $501 · 2025 $228

Food & beverage: $228
CompanyPaymentsAmount
Janssen Biotech, Inc.2$37
Merck Sharp & Dohme LLC1$30
AstraZeneca Pharmaceuticals LP1$28
ABBVIE INC.1$27
Karyopharm Therapeutics Inc.1$24
Bayer Healthcare Pharmaceuticals Inc.1$23
Astellas Pharma US Inc1$21
Novartis Pharmaceuticals Corporation1$20
Agios Pharmaceuticals, Inc.1$18

Products named: KEYTRUDA, LYNPARZA, IMBRUVICA, XPOVIO, Nubeqa, ERLEADA, Xtandi, SCEMBLIX.

Industry payments across CA — which companies pay providers there.